130 related articles for article (PubMed ID: 33929114)
21. Piperacillin/tazobactam plus amikacin versus carbapenem monotherapy as empirical treatment of febrile neutropenia in childhood hematological malignancies.
Yildirim I; Aytac S; Ceyhan M; Cetin M; Tuncer M; Cengiz AB; Secmeer G; Yetgin S
Pediatr Hematol Oncol; 2008 Jun; 25(4):291-9. PubMed ID: 18484473
[TBL] [Abstract][Full Text] [Related]
22. Can complications in febrile neutropenia be predicted? Report from a developing country.
Oberoi S; Das A; Trehan A; Ray P; Bansal D
Support Care Cancer; 2017 Nov; 25(11):3523-3528. PubMed ID: 28601903
[TBL] [Abstract][Full Text] [Related]
23. Dengue fever as a cause of febrile neutropenia in adult acute lymphoblastic leukemia: a single center experience.
Jain H; Sengar M; Menon H; Dangi U; Biswas S; Chandrakanth MV
Hematol Oncol Stem Cell Ther; 2014 Sep; 7(3):125-6. PubMed ID: 24793316
[No Abstract] [Full Text] [Related]
24. Early Discharge of Neutropenic Pediatric Oncology Patients Admitted With Fever.
Villanueva MA; August KJ
Pediatr Blood Cancer; 2016 Oct; 63(10):1829-33. PubMed ID: 27196265
[TBL] [Abstract][Full Text] [Related]
25. [Respiratory virus infections in children with acute lymphoblastic leukemia and febrile neutropenia: a prospective study].
Täger F M; Zolezzi R P; Folatre B I; Navarrete C M; Rojas P J
Rev Chilena Infectol; 2006 Jun; 23(2):118-23. PubMed ID: 16721444
[TBL] [Abstract][Full Text] [Related]
26. The impact of pretreatment serum cobalamin and folate levels on complications and peripheral blood recovery during induction chemotherapy of leukemia: a cross-sectional study.
Köse V; Bilir ÖA; Kara A; Özbek NY; Yaralı HN
Support Care Cancer; 2021 Apr; 29(4):2225-2230. PubMed ID: 32895740
[TBL] [Abstract][Full Text] [Related]
27. Risk of repeated febrile episodes during chemotherapy-induced granulocytopenia in children with cancer: a prospective single center study.
Bagnasco F; Haupt R; Fontana V; Valsecchi MG; Rebora P; Caviglia I; Caruso S; Castagnola E
J Chemother; 2012 Jun; 24(3):155-60. PubMed ID: 22759760
[TBL] [Abstract][Full Text] [Related]
28. Factors predicting outcome in high risk febrile neutropenia in patients receiving intensive chemotherapy for acute sleukemia: A prospective, observational study from South India.
Rajendranath R; Balasubramaniyum VK; Vijayakumar V; Ganesan P; Tenali GS
Indian J Cancer; 2014; 51(4):481-6. PubMed ID: 26842171
[TBL] [Abstract][Full Text] [Related]
29. SARS-CoV-2 infection in children with febrile neutropenia.
Flores V; Miranda R; Merino L; González C; Serrano C; Solano M; Herrera J; González P; Ruiz G; Saldaña R; Cárdenas A; Chávez-Aguilar LA
Ann Hematol; 2020 Aug; 99(8):1941-1942. PubMed ID: 32529285
[No Abstract] [Full Text] [Related]
30. Increased endogenous thrombin generation in children with acute lymphoblastic leukemia: risk of thrombotic complications in L'Asparaginase-induced antithrombin III deficiency.
Mitchell L; Hoogendoorn H; Giles AR; Vegh P; Andrew M
Blood; 1994 Jan; 83(2):386-91. PubMed ID: 8286739
[TBL] [Abstract][Full Text] [Related]
31. Febrile neutropenia in children with cancer: a retrospective Norwegian multicentre study of clinical and microbiological outcome.
Stabell N; Nordal E; Stensvold E; Gammelsrud KW; Lund B; Taxt A; Buhring F; Greve-Isdahl M; Fornebo HP; Simonsen GS; Klingenberg C
Scand J Infect Dis; 2008; 40(4):301-7. PubMed ID: 17918015
[TBL] [Abstract][Full Text] [Related]
32. Infection-related complications during treatment for childhood acute lymphoblastic leukemia.
Inaba H; Pei D; Wolf J; Howard SC; Hayden RT; Go M; Varechtchouk O; Hahn T; Buaboonnam J; Metzger ML; Rubnitz JE; Ribeiro RC; Sandlund JT; Jeha S; Cheng C; Evans WE; Relling MV; Pui CH
Ann Oncol; 2017 Feb; 28(2):386-392. PubMed ID: 28426102
[TBL] [Abstract][Full Text] [Related]
33. Thrombin generation in children with acute lymphoblastic leukemia: effect of leukemia immunophenotypic subgroups.
Giordano P; Del Vecchio GC; Santoro N; Arcamone G; Coppola B; Altomare M; Schettini F; Iolascon A; De Mattia D
Pediatr Hematol Oncol; 2000 Dec; 17(8):667-72. PubMed ID: 11127398
[TBL] [Abstract][Full Text] [Related]
34. PROGNOSIS OF THE COURSE OF CHORNOBYL-ORIGINATED ACUTE LYMPHOBLASTIC LEUKEMIA IN CHILDREN IN UKRAINE DEPENDING ON THE REASON OF STANDARD CHEMOTHERAPY INTERRUPTION.
Bebeshko VG; Bruslova KM; Tsvetkova NM; Lyashenko LO; Pushkariova TI; Gonchar LO; Tryhlib IV; Yatsemirskyi SM; Samson YM; Boyarskyi VG; Grischenko KV; Polyanska VM; Dmytrenko IV
Probl Radiac Med Radiobiol; 2019 Dec; 24():335-349. PubMed ID: 31841478
[TBL] [Abstract][Full Text] [Related]
35. Severe infections in children with acute leukemia undergoing intensive chemotherapy can successfully be prevented by ciprofloxacin, voriconazole, or micafungin prophylaxis.
Yeh TC; Liu HC; Hou JY; Chen KH; Huang TH; Chang CY; Liang DC
Cancer; 2014 Apr; 120(8):1255-62. PubMed ID: 24415457
[TBL] [Abstract][Full Text] [Related]
36. Ciprofloxacin reduces occurrence of fever in children with acute leukemia who develop neutropenia during chemotherapy.
Laoprasopwattana K; Khwanna T; Suwankeeree P; Sujjanunt T; Tunyapanit W; Chelae S
Pediatr Infect Dis J; 2013 Mar; 32(3):e94-8. PubMed ID: 23080291
[TBL] [Abstract][Full Text] [Related]
37. Folate deficiency in north Indian children undergoing maintenance chemotherapy for acute lymphoblastic leukemia-Implications and outcome.
Roy Moulik N; Kumar A; Agrawal S; Mahdi AA
Pediatr Blood Cancer; 2018 Jan; 65(1):. PubMed ID: 28766851
[TBL] [Abstract][Full Text] [Related]
38. Febrile neutropenia in children with acute lymphoblastic leukemia: single center experience.
Özdemir N; Tüysüz G; Çelik N; Yantri L; Erginöz E; Apak H; Özkan A; Yıldız İ; Celkan T
Turk Pediatri Ars; 2016 Jun; 51(2):79-86. PubMed ID: 27489464
[TBL] [Abstract][Full Text] [Related]
39. Plasma presepsin level is an early diagnostic marker of severe febrile neutropenia in hematologic malignancy patients.
Koizumi Y; Shimizu K; Shigeta M; Okuno T; Minamiguchi H; Kito K; Hodohara K; Yamagishi Y; Andoh A; Fujiyama Y; Mikamo H
BMC Infect Dis; 2017 Jan; 17(1):27. PubMed ID: 28056845
[TBL] [Abstract][Full Text] [Related]
40. c-D-index is a risk factor for prolonged febrile neutropenia during chemotherapy in patients with acute myeloid leukemia.
Kubo H; Imataki O; Kubo YH; Uemura M; Kadowaki N
Int J Clin Oncol; 2019 May; 24(5):590-595. PubMed ID: 30604157
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
